A renal transplant recipient with CMV pneumonia received ganciclovir and thymosin alpha‑1, reduced immunosuppression and recovered, and was discharged on day 81 after surgery.
In plain wordsOne kidney transplant patient given ganciclovir, thymosin alpha‑1 and reduced immunosuppressants recovered; the effect of thymosin alone is not known.
- Peptide
- Thymosin alpha-1
- Outcome
- Not applicableRecovery and discharge of a renal transplant recipient with CMV pneumonia
- Study
n = 1
- Outcome group
- Infection and antimicrobial activity · Infection
Source sentences
Fourteen days after the aforementioned therapy, the patient began to recover and she was discharged on day 81 postoperatively.
2 context sentences(design, population, supporting numbers)
we administered gancyclovir and thymosin α1 but reduced the strength of the immunosuppressive drugs
The case we describe was that of a 47-year-old woman with history of renal transplantation 1 month earlier.
In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.